In 350 adults with H pylori after at least one failed eradication, 14-day vonoprazan-tetracycline dual therapy was non-inferior to bismuth quadruple therapy (mITT eradication 90.6% vs 89.3%), with fewer adverse events (10.9% vs 45.7%).
RCTn = 350
Gao et al. Vonoprazan-Tetracycline Dual Regimen as Rescue Therapy for Helicobacter pylori Infection: Randomized Controlled Trial